Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non-small-cell lung cancer

BACKGROUND: Little evidence has been generated for how best to manage patients with non-small-cell lung cancer (nsclc) presenting with rarer clinical scenarios, including oligometastases, oligoprogression, and pseudoprogression. In each of those scenarios, oncologists have to consider how best to ba...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Laurie, S.A., Banerji, S., Blais, N., Brule, S., Cheema, P.K., Cheung, P., Daaboul, N., Hao, D., Hirsh, V., Juergens, R., Laskin, J., Leighl, N., MacRae, R., Nicholas, G., Roberge, D., Rothenstein, J., Stewart, D.J., Tsao, M.S.
Formato: Artigo
Idioma:Inglês
Publicado em: Multimed Inc. 2019
Assuntos:
Practice Guideline
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380642/
https://ncbi.nlm.nih.gov/pubmed/30853813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4116
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados